Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Insmed, a global biopharmaceutical company, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024, in Miami. Management will engage in a fireside chat at 10:00 a.m. ET, which will be webcast live. The webcast will be accessible via Insmed's investor relations website and will remain archived for 30 days post-event.

Positive

• Insmed's participation in the Goldman Sachs 45th Annual Global Healthcare Conference could increase visibility and attract investor interest.
• A webcast of the event will be available, enhancing transparency and access to information for investors.
• The event offers a platform for Insmed to discuss its strategic initiatives, potentially boosting investor confidence.

Negative

• The announcement lacks specific financial or clinical updates, which might be seen as a missed opportunity for detailed progress reporting.
• No new product or pipeline developments are mentioned, possibly leaving investors seeking more substantial news disappointed.

BRIDGEWATER, N.J., June 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the Goldman Sachs 45^th Annual Global Healthcare Conference in Miami on Monday, June 10, 2024, at 10:00 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is also advancing an early-stage research engine encompassing a wide range of technologies and modalities, including artificial intelligence-driven protein engineering, gene therapy, and protein manufacturing. Insmed is headquartered in Bridgewater, New Jersey, with additional offices and research locations throughout the United States, Europe, and Japan. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-goldman-sachs-45th-annual-global-healthcare-conference-302163361.html

SOURCE Insmed Incorporated

FAQ

When will Insmed present at the Goldman Sachs 45th Annual Global Healthcare Conference?

Insmed will present on June 10, 2024, at 10:00 a.m. ET.

How can I access the webcast of Insmed's presentation at the Goldman Sachs conference?

The webcast can be accessed via the investor relations section of Insmed's website, and it will be archived for 30 days post-event.

What is the stock symbol for Insmed?

The stock symbol for Insmed is INSM.

Where will the Goldman Sachs 45th Annual Global Healthcare Conference take place?

The conference will take place in Miami.

Will Insmed provide new clinical data or financial updates at the conference?

The press release does not specify any new clinical data or financial updates to be presented at the conference.